Globus Medical (GMED)
(Delayed Data from NYSE)
$71.07 USD
+0.32 (0.45%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $71.08 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth D Momentum B VGM
Price, Consensus and EPS Surprise
GMED 71.07 +0.32(0.45%)
Will GMED be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for GMED based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GMED
Here's Why Globus Medical (GMED) is a Strong Growth Stock
Here's Why Globus Medical (GMED) is a Strong Growth Stock
GMED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Globus Medical, Inc. (GMED) Hits Fresh High: Is There Still Room to Run?
GMED vs. SONVY: Which Stock Is the Better Value Option?
Here's Why Globus Medical (GMED) is a Strong Value Stock
Other News for GMED
Buy Rating Affirmed: Globus Medical’s Strategic Entry into Joint Reconstruction Robotics and Growth Potential
Globus Medical: Hold Rating Amid Modest Short-Term Impact from ExcelsiusFlex Approval
First Week of August 16th Options Trading For Globus Medical (GMED)
Globus Medical (GMED) Gets a Buy from RBC Capital
Orthofix appoints McPherron as President of Global Operations, Quality